Syra Health Corp (SYRA): Insider Trading, Congress Trades & Research | Tormere
SYRA
$0.93+0.02%
Syra Health Corp
Market Cap
$13M
Live price × SEC shares (Nov 3, 2026)
Sector
Health Care
Industry
Health Care
Beta (raw)
3.29
37mo monthly vs SPY
P/E (TTM)
23.3
TTM to Sep 2026 · diluted EPS
P/S (TTM)
1.4
TTM to Sep 2026 · revenue
P/B
4.3
Mkt cap / shareholders' equity
EV/EBITDA (TTM)
—
EV / TTM EBITDA
Loading…
Financial Statements
USD thousands
Q4 FY2025
Dec 31, 2025
Q1 FY2026
Mar 31, 2026
Q2 FY2026
Jun 30, 2026
Q3 FY2026
Sep 30, 2026
TTM
Sep 30, 2026
Revenue
1,734
2,274
2,394
2,557
8,959
Cost of revenue
1,143
1,302
1,328
1,372
5,145
Gross profit
591
971
1,066
1,185
3,814
Research & development
0
7
47
47
101
Selling, general & administrative
237
213
236
222
908
Total operating expenses
727
780
815
885
3,207
Operating income
(136)
191
252
300
607
Interest expense
4.3
2.5
2.2
1.4
10.3
Pretax income
300
Income tax
(45.0)
Net income
(135)
241
250
345
701
EPS (basic) ($)
0.02
0.02
0.02
0.04
EPS (diluted) ($)
0.02
0.02
0.02
0.04
Weighted avg. shares (basic)
11,939
13,175
14,194
Weighted avg. shares (diluted)
12,781
13,552
15,142
Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 13 more quarters, back to Sep 2022, with Tormere Pro.
